Skip to main content

and
  1. Article

    Open Access

    Patient-reported functional outcome measures and treatment choice for prostate cancer

    The aim of this study was to describe changes in patient-reported functional outcome measures (PROMs) comparing pre-treatment and 12 months after radical prostatectomy (RP), external beam radiation therapy (EB...

    Tenaw Tiruye, Michael O’Callaghan, Kim Moretti, Alex Jay, Braden Higgs in BMC Urology (2022)

  2. No Access

    Article

    Active surveillance for intermediate risk prostate cancer could be risky for the patient

    Kim Moretti in World Journal of Urology (2022)

  3. No Access

    Article

    PSA response to antiandrogen withdrawal: a systematic review and meta-analysis

    Antiandrogen withdrawal (AAW) response is the paradoxical decrease in prostate-specific antigen (PSA) following the withdrawal of antiandrogen in patients with advanced prostate cancer. Currently, the reported...

    Alwin Soo, Michael E. O’Callaghan, Tina Kopsaftis in Prostate Cancer and Prostatic Diseases (2021)

  4. No Access

    Article

    Prostate cancer mortality is high in the elderly and can be reduced by selective individualized curative treatment

    Kim Moretti, Sina Vatandoust, Ganessan Kichenadasse in World Journal of Urology (2018)

  5. No Access

    Article

    ISUP Group 4 – a Homogenous Group of Prostate Cancers?

    The International Society of Urological Pathology (ISUP) and the World Health Organisation have adopted a five-tiered prognostic grade group for prostate cancer in 2014. Grade group 4 is comprised of Gleason p...

    Thomas Chengxuan Lu, Kim Moretti, Kerri Beckmann in Pathology & Oncology Research (2018)

  6. Article

    Open Access

    An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review

    Prostate cancer can be treated with several different modalities, including radiation treatment. Various prognostic tools have been developed to aid decision making by providing estimates of the probability of...

    Elspeth Raymond, Michael E. O’Callaghan, Jared Campbell in Radiation Oncology (2017)

  7. No Access

    Article

    Prostate cancer outcomes and delays in care

    To examine the survival effect of treatment delays from the time of confirmed diagnosis of prostate cancer to first treatment in an Australian population.

    Michael E. O’Callaghan, Zumin Shi, Tina Kopsaftis in International Urology and Nephrology (2017)

  8. Article

    Open Access

    A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease

    Prostate cancer (PCa) is the most commonly diagnosed malignancy reported to Australian cancer registries with numerous studies from individual registries summarizing diagnostic and treatment characteristics. T...

    Rasa Ruseckaite, Kerri Beckmann, Michael O’Callaghan, David Roder in BMC Cancer (2016)

  9. Article

    Open Access

    Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset

    Prostate cancer is the most commonly diagnosed and prevalent malignancy reported to Australian cancer registries, with numerous studies from single institutions summarizing patient outcomes at individual hospi...

    Rasa Ruseckaite, Kerri Beckmann, Michael O’Callaghan, David Roder in BMC Research Notes (2016)